HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
18 hedge funds and large institutions have $864K invested in Hepion Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$186K | |
| 2 | +$21.4K | |
| 3 | +$15K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.41K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.75K |
Top Sellers
| 1 | -$43.8K | |
| 2 | -$369 | |
| 3 | -$295 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$221 |
| 5 |
AF
Advisornet Financial
Minnetonka,
Minnesota
|
-$148 |